Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03DXS
|
||||
| Former ID |
DIB007867
|
||||
| Drug Name |
Odapipam
|
||||
| Synonyms |
NNC 0756; NNC-756; NNC-01-0756
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Discontinued in Phase 1 | [546051] | ||
| Company |
Novo Nordisk A/S
|
||||
| Formula |
C19H20ClNO2
|
||||
| Canonical SMILES |
[C@@H]1(c2c3c(ccc2)CCO3)c2c(cc(c(c2)O)Cl)CCN(C1)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dopamine D1 receptor | Target Info | Antagonist | [525486] | |
| PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.